Physician

Priya Vakharia, MD

According to 2025 Medicare claims, Priya Vakharia, MD (NPI: 1215279500) practices ophthalmology in the St. Petersburg-Clearwater-Largo, FL market, with the plurality of this provider's patient population coming from Pinellas, FL. This provider's primary affiliated billing organization is PAUTLER COHEN FINDLAY EICHENBAUM WHITE AND CRANE MDS PA (NPI: 1881712859; TIN: 591501675) and primary practice location at 34684-3425.

Vakharia's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 588 traditional Medicare patients, billed 32,922 HCPCS/CPT codes, and received $1,362,369 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 362 prescription claims across 124 beneficiaries totaling $30,074 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 176 records totaling $175,075. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $8,289 to $1,362,369. Similarly, Part D prescription costs have moved sharply higher in recent years, from $40,521 to $30,074. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$681K$1.4M2017 Medicare payment: $8,289 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $37,219 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $59,777 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,243,769 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $770,775 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $645,238 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,190,229 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,362,369 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
20174662$8,289
2018211300$37,219
2019199493$59,777
20208187,480$1,243,769
20215974,512$770,775
20223624,211$645,238
202353220,150$1,190,229
202458832,922$1,362,369

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$33K$66K2015 Drug cost: $40,521 (USD; Tot_Drug_Cst)2016 Drug cost: $39,958 (USD; Tot_Drug_Cst)2017 Drug cost: $37,918 (USD; Tot_Drug_Cst)2018 Drug cost: $29,058 (USD; Tot_Drug_Cst)2019 Drug cost: $15,401 (USD; Tot_Drug_Cst)2020 Drug cost: $15,532 (USD; Tot_Drug_Cst)2021 Drug cost: $21,108 (USD; Tot_Drug_Cst)2022 Drug cost: $65,604 (USD; Tot_Drug_Cst)2023 Drug cost: $58,206 (USD; Tot_Drug_Cst)2024 Drug cost: $30,074 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015201663$40,521
2016217734$39,958
2017232709$37,918
2018202454$29,058
201974146$15,401
202093284$15,532
202168251$21,108
202279202$65,604
2023117354$58,206
2024124362$30,074

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more211367$87
67028Injection of drug into eye181615$86
92014Established patient complete exam of visual system246313$83
92134Imaging of retina5091,117$27
92250Photography of the retina165216$25

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RestasisCyclosporine11510$10,728
Prednisolone AcetatePrednisolone Acetate773,376$4,313
Ketorolac TromethamineKetorolac Tromethamine321,228$715
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat603,857$449
Gentamicin SulfateGentamicin Sulfate431,041$292

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.172$164,779Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.4$10,296Regeneron Pharmaceuticals, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Priya Vakharia, MD?

Tedicare shows public-source Medicare data for Priya Vakharia, MD (NPI 1215279500), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Priya Vakharia, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Priya Vakharia, MD?

Priya Vakharia, MD is linked to PAUTLER COHEN FINDLAY EICHENBAUM WHITE AND CRANE MDS PA (billing NPI 1881712859) in the available physician profile data.

Does Priya Vakharia, MD have Open Payments data?

Priya Vakharia, MD has 176 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.